Barcelona Bio-HF calculator version 3.0: recalibration and incorporation of sodium-glucose cotransporter 2 inhibitor treatment

Eur J Heart Fail. 2023 Jan;25(1):131-132. doi: 10.1002/ejhf.2752. Epub 2022 Dec 20.

Authors

Pau Codina^{1

2}, Josep Lupón^{1

2

3}, Isaac Subirana^{3

4}, Elisabet Zamora^{1

2

3}, Mar Domingo¹, Evelyn Santiago-Vacas¹, Germán Cediel¹, Andrea Borrellas¹, Jaume Barallat⁵, Antoni Bayes-Genis^{1

2

3}

Affiliations

¹ Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
² Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
³ CIBERCV, Instituto de Salud Carlos III, Madrid, Spain.
⁴ IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
⁵ Biochemistry Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

PMID: 36519628
DOI: 10.1002/ejhf.2752

No abstract available

Publication types

Letter

MeSH terms

Diabetes Mellitus, Type 2* / drug therapy
Glucose
Heart Failure* / drug therapy
Heart Failure* / metabolism
Humans
Sodium
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

Sodium-Glucose Transporter 2 Inhibitors
Glucose
Sodium